Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2005
06/01/2005EP1423002A4 Use of cross-linked, covalently bound urokinase plasminogen activator (scupa)-urokinase plasminogen activator receptor (supar) complex as a fibrinolytic agent
06/01/2005EP1411926B1 Integrin inhibitors for the treatment of eye diseases
06/01/2005EP1404362A4 Signal-1/signal-2 bifunctional peptide inhibitors
06/01/2005EP1263884B1 Process for the preparation of micronised collagen, and its therapeutic applications
06/01/2005EP1218064B1 COMPOSITIONS FOR TREATING AUTOIMMUNE DISEASEs CONTAINING A COMPOUND WHICH INHIBITS ICAM-LFA-1 INTERACTION AND A COMPOUND WHICH INHIBITS CD40-CD40 LIGAND INTERACTION
06/01/2005EP1218018A4 Use of colostrinin, constituent peptides thereof, and analogs thereof as oxidative stress regulators
06/01/2005EP1157041B1 Antibodies for cancer therapy and diagnosis
06/01/2005EP1150725B1 Osteogenic paste compositions and uses thereof
06/01/2005EP1143927B1 Facial tissue composition and method of use for sequestration of nasal secretion skin irritants
06/01/2005EP1042460B1 Brain or heart cyclic nucleotide gated ion channel compounds and uses thereof
06/01/2005EP1024839B1 Reverse phase connective tissue repair composition
06/01/2005EP1009758B1 Meta-benzamidine derivatives as serine protease inhibitors
06/01/2005EP0981353B1 Facilitation of repair of neural injury with cm101/gbs toxin
06/01/2005EP0954573B1 Preparation of ionically cross-linked polyphosphazene microspheres by coacervation
06/01/2005EP0906433B1 Protein tyrosine phosphatases of hematopoietic cells
06/01/2005EP0794963B1 Xanthine derivatives compounds useful for activating chloride conductance in animal cells
06/01/2005EP0769059B1 Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms
06/01/2005CN1623001A System for monitoring bacterial tumor treatment
06/01/2005CN1622995A Receptor nucleic acids and polypeptides
06/01/2005CN1622994A TGF-beta-specific covalently closed antisense molecule
06/01/2005CN1622992A Synthetic peptides and methods for treating cancer invasion and metastasis
06/01/2005CN1622958A Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
06/01/2005CN1622957A IFNAR2 mutants, their production and use
06/01/2005CN1622956A Cytotoxic cyplasin of the sea hare, aplysia punctata, cdna cloning and expression of bioreactive recombinants
06/01/2005CN1622955A Tumor tag and the use thereof
06/01/2005CN1622953A Peptide derivative, and pharmaceutically acceptable salt thereof, process for producing the same, and use thereof
06/01/2005CN1622942A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
06/01/2005CN1622941A Glutaminyl based DPIV inhibitors
06/01/2005CN1622830A Peptide-based compounds
06/01/2005CN1622828A Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
06/01/2005CN1622827A Thrombin derived peptides for promoting cardiac tissue repair
06/01/2005CN1622826A Stimulation of bone growth and cartilage formation with thrombing peptide derivatives
06/01/2005CN1622823A Purification of red blood cells by separation and infiltration
06/01/2005CN1622822A Medicinal compositions containing ghrelin
06/01/2005CN1622821A Method of stimulating growth and resistance to diseases of aquatic organisms
06/01/2005CN1622801A Method and device for feeding living cells into a biological body fluid
06/01/2005CN1622797A Methods and compositions for the promotion of hair growth utilizing actin binding peptides
06/01/2005CN1622760A A process for the extraction, purification and enzymatic modification of soy 7S globulin alpha' subunit for use as hypocholesterolemizing agent
06/01/2005CN1621414A Antigenic determinant polypeptide of human tumor-testis antigen HCA587 and use thereof
06/01/2005CN1621411A Recombinant targeted fusion protein for treating acquired immunodeficiency syndrome
06/01/2005CN1620935A Amylose, polypeptide functional blueberry drink and production process
06/01/2005CN1204259C Production process of human lysozyme as AIDS treating medicine with plant as bioreactor
06/01/2005CN1204258C Component of bromelain
06/01/2005CN1204250C Method for producing cumic(natto) kinase
06/01/2005CN1204248C Process for preparing target ribonuclease for curing hepatitis B virus infection
06/01/2005CN1204144C Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
06/01/2005CN1204143C Crystalline forms of EtO2C-CH2-(R)Cgl-Aze-Pab-OH
06/01/2005CN1203897C Sustained release salts of pharmaceutically active peptides and production thereof
06/01/2005CN1203892C Aqueous solution formulation of alpha-interferon
06/01/2005CN1203852C Valdecoxib compositions
06/01/2005CN1203851C Use of inhibitor produced or released by reactive oxygen metablite in producing pharmaceutical
06/01/2005CN1203847C Chemically-defined non-polymeric valency plateform molecules and conjugates thereof
05/2005
05/31/2005US6900367 Transgenic Drosophila melanogaster expressing a β42 in the eye
05/31/2005US6900319 Carbo- and heterocyclic amidines
05/31/2005US6900317 Calcitonin gene related peptide antagonist; spray dried powder
05/31/2005US6900306 Antisense modulation of CoREST expression
05/31/2005US6900297 A compound which hybridizes with a nucleic acid includes multiple inked nucleosides (inlcudes a pentofuranosyl sugar portion and a base portion), and at least one sugar o-is terminated with R-N(R1a R1b) substitutent
05/31/2005US6900292 Fusion protein for use in the treatment of anemia, cancer, arthritis and infections
05/31/2005US6900288 Comprises membrane glycoproteins for diagnosis, prevention and treatment of nervous system and cell proliferative disorders
05/31/2005US6900221 Crystalline polymorph of erlotinib hydrochloride; synthesis; treating cancer
05/31/2005US6900218 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents
05/31/2005US6900213 Controlling fertility; contraceptives; anticancer agents
05/31/2005US6900205 Antidiabetic agents
05/31/2005US6900192 Bile-acid conjugates for providing sustained systemic concentrations of drugs
05/31/2005US6900187 TRPM-2 antisense therapy using an oligonucleotide having 2′-O-(2-methoxy)ethyl modifications
05/31/2005US6900186 Method for the prophylaxis and/or treatment of medical disorders
05/31/2005US6900185 Genetic engineering; binding Dna to apolipoprotein ligand; antitumor agents
05/31/2005US6900180 Mixture of folic acid, vitamin b6 and b12 with carbohydrates, fats and proteins; infant formula; sleep disorders
05/31/2005US6900179 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
05/31/2005US6900178 Protection against ischemia and reperfusion injury
05/31/2005US6900177 Anticholesterol agents; cardiovascular disorders
05/31/2005US6900175 Administering teichoplanin
05/31/2005US6900174 Comprises mineral (chromium and/or vanadium) bound by glycoprotein matrix produced by yeast (Saccharomyces cervisiae); for inhibiting absorption of dietary starch; for obesity and other carbohydrate limited dieting
05/31/2005US6900053 Antisense modulation of fibroblast growth factor receptor 2 expression
05/31/2005US6900045 Nucleotide sequences coding polypeptides for use in human therapeutics, diagnostics and pharmocology
05/31/2005US6900043 Phosphatases which activate map kinase pathways
05/31/2005US6900042 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
05/31/2005US6900040 Isolated human dehydrogenaseproteins, nucleic acid molecules encoding these human dehydrogenase proteins, and uses thereof
05/31/2005US6900039 Catalytic oxidation of oligosaccharides
05/31/2005US6900038 eNOS mutations useful for gene therapy and therapeutic screening
05/31/2005US6900033 Angiotensin converting enzyme-2/like polypeptides and inhibitors for treating and/or prevention of hypertension, congestive heart failure, stroke and atherosclerotic heart disease
05/31/2005US6900032 Human PTTG polypeptide and method for producing it
05/31/2005US6900031 Endothelial and Smooth muscle cell-Derived Neuropilin-like molecule; effective in restenosis after percutaneous transluminal coronany angioplasty and arterial sclerosis
05/31/2005US6900024 A T cell receptor ligand which substantially inhibits at least one T cell effector response evoked by fully active peptide-MHC(major histocompatibility complex) available to respond T cells
05/31/2005US6900020 Identifying prorenin modulators for treatment of cardiovascular and organ hypertrophy; enzyme inhibitors; mimetics
05/31/2005US6899891 Nutritional composition, methods of producing said composition and methods of using said composition
05/31/2005US6899885 74-kilodalton outer membrane protein from Moraxella catarrhalis
05/31/2005US6899883 Treatment of diabetes
05/31/2005US6899882 Endothelial cell growth factor methods of isolation and expression
05/31/2005US6899879 Method for treating an IgE-mediated disease in a patient using anti-CD40 monoclonal antibodies
05/31/2005US6899878 Antibodies to interleukin-1 receptor intracellular ligand proteins
05/31/2005US6899876 Compositions and methods relating to reduction of symptoms of autism
05/31/2005US6899875 Methods and compositions relating to CD39-like polypeptides and nucleic acids
05/31/2005US6899874 Method for the treatment of bacterial vaginal infections
05/31/2005US6899869 Method of preparing an animal model for interstitial pneumonia
05/31/2005CA2137595C Treating hormone-dependent conditions
05/26/2005WO2005047906A1 Methods for monitoring il-18
05/26/2005WO2005047905A1 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 22 (gpr22)
05/26/2005WO2005047902A1 Solution-based methods for detecting mhc-binding peptides
05/26/2005WO2005047537A2 Diagnosis of distal hereditary motor neuropathy type ii by detection of hsp22 gene polymorphisms
1 ... 1436 1437 1438 1439 1440 1441 1442 1443 1444 1445 1446 1447 1448 1449 1450 1451 1452 1453 1454 1455 1456 ... 3163